merck glp 1 agonist Trends in the Development of GLP-1 Receptor Agonists Oral GLP-1 receptor agonists: competition
Description
Biopharm Drug Dispos
00360-0/asset/06397771-b461-4bfd-bc69-cd0a43d464aa/main.assets/fx1.jpg)
In addition to TCF7L2, several other genetic loci have been identified to be associated with reduced GLP-1-induced insulin secretion, including the loci for GLP-1R [563], wolfram syndrome 1 ( WFS1) [564] and chymotrypsinogen B1/2 ( CTRB1/2) [565]
Insulin and Insulin Resistance
Future products may combine basal insulin with newer, more potent GLP-1 or dual GIP/GLP-1 receptor agonists
Effects of liraglutide on cardiovascular risk factors in patients with type 1 diabetes
Overall, dual agonists are showing efficacy in both weight and cardiovascular risk reduction
